Cart
sales@molnova.com
Cobimetinib racemate
CAS No. 934662-91-6
Cobimetinib racemate( GDC-0973 racemate | XL-518 | GDC 0973 | XL 518 | GDC0973 | XL518 )
Catalog No. M16684 CAS No. 934662-91-6
Cobimetinib racemate is the racemate form of Cobimetinib (GDC-0973, XL518), which is a potent, highly selective inhibitor of MEK1/2.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 717 | Get Quote |
|
| 100MG | 1071 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCobimetinib racemate
-
NoteResearch use only, not for human use.
-
Brief DescriptionCobimetinib racemate is the racemate form of Cobimetinib (GDC-0973, XL518), which is a potent, highly selective inhibitor of MEK1/2.
-
DescriptionCobimetinib racemate is the racemate form of Cobimetinib (GDC-0973, XL518), which is a potent, highly selective inhibitor of MEK1/2.
-
In Vitro——
-
In Vivo——
-
SynonymsGDC-0973 racemate | XL-518 | GDC 0973 | XL 518 | GDC0973 | XL518
-
PathwayMAPK/ERK Signaling
-
TargetMEK
-
RecptorMEK
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number934662-91-6
-
Formula Weight531.31
-
Molecular FormulaC21H21F3IN3O2
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 40 mg/mL
-
SMILESO=C(C1=CC=C(F)C(F)=C1NC2=CC=C(I)C=C2F)N3CC(C4NCCCC4)(O)C3
-
Chemical NameMethanone, [3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl][3-hydroxy-3-(2-piperidinyl)-1-azetidinyl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
TAOK inhibitor 43
TAOK inhibitor 43 is a novel potent, selective, ATP-competitive TAO Kinase (TAOK) inhibitor with IC50 of 11 and 15 nM against TAOK1 and TAOK2, respectively.
-
EBI-1051
EBI-1051 is a novel and orally efficacious MEK inhibitor with IC50 of 10.8 nM against MEK1.
-
GNE-3511
GNE-3511 is a potent, selective, orally bioavailable, brain-penetrant dual leucine zipper kinase (DLK, MAP3K12) inhibitor with Ki of <0.5 nM.
